A new generation of checkpoint inhibitors is emerging, with some showing more promise than others. From recent TIGIT failures ...

The restrictions on Novavax's vaccine could portend changes at the FDA. Commissioner Marty Makary suggested last week that ...

In a year when eradicated diseases are on the uptick in America, how will American children survive RFK Jr.’s vaccine ...

Analysts at BMO Capital Markets said in a weekend note that a non-invasive blood test could help boost uptake of Alzheimer’s ...

Govorestat failed to meet its primary endpoint in a Phase II/III trial for a rare form of Charcot-Marie-Tooth disease, a few ...

DB-OTO, which Regeneron obtained from the 2023 acquisition of Decibel Therapeutics for $109 million, works by delivering a ...

Taking center stage at the American Society of Gene and Cell Therapy meeting was the first-ever reported case of a ...

Sponsored communities reduce timelines and increase relevance. Digital engagement allows for rapid study launches and ...